References
- Troost D., van den Oord J. J., de Jong J. M., Swaab D. F. Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis. Clin Neuropathol 1989; 8: 289–94
- Lampson L. A., Kushner P. D., Sobel R. A. Major histocompatibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis. Ann Neurol 1990; 28: 365–72
- Engelhardt J. I., Tajti J., Appel S. H. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch Neurol 1993; 50: 30–6
- Graves M. C., Fiala M., Dinglasan L. A., Liu N. Q., Sayre J., Chiappeli F., et al. Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, masT‐cells and T‐cells. Amyotroph Lateral Scler Other Motor Neuron Disord 2004; 5: 213–9
- Vass K., Lassmann H. Intrathecal application of interferon gamma. Progressive appearance of MHC antigens within the rat nervous system. Am J Pathol 1990; 137: 789–800
- Ford L., Rowe D. Interleukin‐12 and interferon‐gamma are not detectable in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2004; 5: 118–20
- Fassbender K., Mielke O., Bertsch T., Muelhauser F., Hennerici M., Kurimoto M., et al. Interferon‐gamma‐inducing factor (IL‐18) and interferon‐gamma in inflammatory CNS diseases. Neurology 1999; 53: 1104–6
- Vladic A., Horvat G., Vukadin S., Sucic Z., Simaga S. Cerebrospinal fluid and serum protein levels of tumour necrosis factor‐alpha (TNF‐alpha) interleukin‐6 (IL‐6) and soluble interleukin‐6 receptor (sIL‐6R gp80) in multiple sclerosis patients. Cytokine 2002; 20: 86–9
- Baraczka K., Nekam K., Pozsonyi T., Szuts I., Ormos G. Investigation of cytokine (tumour necrosis factor‐alpha, interleukin‐6, interleukin‐10) concentrations in the cerebrospinal fluid of female patients with multiple sclerosis and systemic lupus erythematosus. Eur J Neurol 2004; 11: 37–42
- Alcocer‐Varela J., Aleman‐Hoey D., Alarcon‐Segovia D. Interleukin‐1 and interleukin‐6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T‐cell activation markers. Lupus 1992; 1: 111–7
- Ichiyama T., Shoji H., Kato M., Sawaishi Y., Ozawa H., Matsubara T., et al. Cerebrospinal fluid levels of cytokines and soluble tumour necrosis factor receptor in acute disseminated encephalomyelitis. Eur J Pediatr 2002; 161: 133–7
- Kondrusik M., Swierzbinska R., Pancewicz S., Zajkowska J., Grygorczuk S., Hermanowska‐Szpakowicz T. Evaluation of proinflammatory cytokine (TNF‐alpha, IL‐1beta, IL‐6, IFN‐gamma) concentrations in serum and cerebrospinal fluid of patients with neuroborreliosis. Neurol Neurochir Pol 2004; 38: 265–70
- Gallo P., Sivieri S., Rinaldi L., Yan X. B., Lolli F., De Rossi. A., et al. Intrathecal synthesis of interleukin‐10 (IL‐10) in viral and inflammatory diseases of the central nervous system. J Neurol Sci 1994; 126: 49–53
- Zhang J., Markovic‐Plese S., Lacet B., Raus J., Weiner H. L., Hafler D. A. Increased frequency of interleukin 2‐responsive T‐cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1994; 179: 973–84
- Hickey W. F., Hsu B. L., Kimura H. T‐lymphocyte entry into the central nervous system. J Neurosci Res 1991; 28: 254–60